Helix BioPharma Corp. has seen notable movement in its stock this week amid recent company activities.
This week, Helix BioPharma Corp. (HBP.TO) experienced a decline of 3.00%, closing at C$1.90. The stock has had a volatile month, with a significant increase of 34.72%, although it remains down 19.17% year-to-date. This price action coincides with various corporate developments, including a private placement and ongoing efforts to secure financing for its therapeutic programs.
Investor takeaway: Keep an eye on Helix BioPharma's financial health and its efforts to secure funding, as these factors will likely influence future stock performance.
Helix BioPharma Corp.
HBP.TO
HBP.TO
Helix BioPharma Corp.
WealthAwesomeMarket cap
$68.74M
52W high
$2.60
52W low
$0.82
1W change
-7.07%
Beta
-0.14
Analyst Price Targets
Based on analyst covering HBP · as of Sep 17, 2026
Wall Street analysts forecast HBP stock price to rise 177.8% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$2.50
+177.8% Upside
Current Price
C$0.90
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on HBP's historical volatility
30-Day Vol
111.5%
Annualized
90-Day Vol
89.1%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.75
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.85 | C$0.58 – C$1.25 |
| 60 trading days | C$0.80 | C$0.46 – C$1.38 |
| 90 trading days | C$0.75 | C$0.39 – C$1.47 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
C$1.90 Closing Price
The stock closed at C$1.90, reflecting a 2.51% decrease on the day.
Bull case
The recent private placement and potential for institutional investment could provide the company with the capital needed to advance its leading therapeutic programs.
Bear case
Concerns about the company's negative profit margins and ongoing losses raise questions about its financial stability and long-term viability.
Recent Price Action
Helix BioPharma Corp. (HBP.TO) saw its stock price decrease by 2.51% on Thursday, with a weekly decline of 3.00%. Despite these short-term dips, the stock has surged 34.72% over the past month, suggesting a volatile trading environment influenced by recent corporate news.
Catalysts Behind the Movement
Recent headlines surrounding Helix BioPharma include the announcement of a private placement of common shares, which raised CAD$3,000,000 for working capital. Additionally, the company is working on securing a USD 13 million bridge financing round to advance its therapeutic programs. These developments indicate that the company is actively seeking to strengthen its financial position, which could be a positive sign for investors.
Technical Picture
From a technical standpoint, Helix BioPharma's last close was C$1.90, which is above its 50-day moving average of C$1.54, indicating a strong short-term trend. The stock is trading close to its 200-day moving average of C$1.88, suggesting stability over a longer period. The 52-week range for HBP.TO is C$1.10 to C$5.40, placing the current price at approximately 19% of that range. With a beta of -0.35, the stock has shown lower volatility compared to the market.
Insider Activity
No recent insider trading activity has been reported for Helix BioPharma Corp., which may indicate a stable management outlook as the company navigates its financial strategies.
Price Action Summary
The stock closed at C$1.90, reflecting a 2.51% decrease for the day. Investors should monitor upcoming announcements and financial reports closely to assess future performance.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
